Medsafe approves Janssen Covid-19 Vaccine in New Zealand

Medsafe approves Janssen Covid-19 Vaccine in New Zealand

Last updated:

Learn our story about how we are independent and what is needed to keep thisquality operating. You might be able to donate to us so we can inform and share what matters faster.

Learn Morearrow

New Zealand’s medicines regulator, Medsafe, approved the Janssen Covid-19 Vaccine on Wednesday.

The Vaccine was given provisional approval by the regulator, which is developed by Janssen — the pharmaceutical unit of Johnson & Johnson.

It will be for use in individuals from 18 years of age and older.


Once provisional approval is given, advice from Ministry of Health officials will then be sent to the Government, who will make decisions around its use.

The Vaccine is safe and effective and will be used as a plan B in certain circumstances if, by chance, Pfizer/BioNTech runs out of stock or has a production issue.

Approval went to Medsafe in April, but additional data was sought as a precaution.


Have time to spare? If you liked this publication, please learn our story to support thisquality. Fund trustworthy news coming from official Government newswires and local voices inside communities.


COVID-19 Coverage

Alert Level 1: PREVENT
*All of New Zealand
*The button below directs to Government Unite Against COVID-19 website.

Notify of
Inline Feedbacks
View all comments